J. Goldman & CO LP Dbv Technologies S.A. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$20.86 - $26.6 $1.22 Million - $1.56 Million	-58,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$20.9 - $49.36 $1.07 Million - $2.53 Million	51,300 Added 712.5%	58,500 $1.44 Million
Q3 2017 Nov 14, 2017	BUY	$39.62 - $46.17 $285,264 - $332,424	7,200	7,200 $306,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $580M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.